Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Treasury Shares (2022 - 2025)

TransMedics has reported Treasury Shares over the past 4 years, most recently at $606483.0 for Q4 2025.

  • Quarterly results put Treasury Shares at $606483.0 for Q4 2025, up 40.96% from a year ago — trailing twelve months through Dec 2025 was $606483.0 (up 40.96% YoY), and the annual figure for FY2025 was $606483.0, up 40.96%.
  • Treasury Shares for Q4 2025 was $606483.0 at TransMedics, up from $430250.0 in the prior quarter.
  • Over the last five years, Treasury Shares for TMDX hit a ceiling of $606483.0 in Q4 2025 and a floor of $9606.0 in Q4 2023.
  • Median Treasury Shares over the past 4 years was $227282.5 (2022), compared with a mean of $267663.5.
  • Biggest five-year swings in Treasury Shares: tumbled 60.49% in 2023 and later surged 4378.97% in 2024.
  • TransMedics' Treasury Shares stood at $24315.0 in 2022, then tumbled by 60.49% to $9606.0 in 2023, then surged by 4378.97% to $430250.0 in 2024, then soared by 40.96% to $606483.0 in 2025.
  • The last three reported values for Treasury Shares were $606483.0 (Q4 2025), $430250.0 (Q4 2024), and $9606.0 (Q4 2023) per Business Quant data.